AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 42 filers reported holding AEROVATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,271,540 | -20.9% | 756,930 | 0.0% | 0.22% | -7.2% |
| Q2 2023 | $12,981,350 | -15.0% | 756,930 | 0.0% | 0.24% | -21.7% |
| Q1 2023 | $15,267,278 | -31.4% | 756,930 | -0.3% | 0.30% | -29.6% |
| Q4 2022 | $22,254,522 | +68.8% | 759,540 | -4.5% | 0.43% | +73.9% |
| Q3 2022 | $13,181,000 | +76.2% | 795,000 | +66.1% | 0.24% | +80.1% |
| Q2 2022 | $7,480,000 | -20.0% | 478,579 | -6.2% | 0.14% | -10.5% |
| Q1 2022 | $9,347,000 | +48.0% | 509,949 | -4.8% | 0.15% | +87.7% |
| Q4 2021 | $6,316,000 | -43.8% | 535,714 | 0.0% | 0.08% | -34.7% |
| Q3 2021 | $11,239,000 | -8.1% | 535,714 | 0.0% | 0.12% | 0.0% |
| Q2 2021 | $12,230,000 | – | 535,714 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 3,758,686 | $78,857,000 | 4.67% |
| RA Capital Management | 8,263,982 | $173,378,000 | 2.40% |
| Cormorant Asset Management, LP | 2,030,691 | $41,962,000 | 1.70% |
| SECTORAL ASSET MANAGEMENT INC | 341,367 | $7,162,000 | 0.60% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 714,285 | $14,986,000 | 0.29% |
| Baker Brothers Advisors | 1,652,171 | $34,663,000 | 0.15% |
| Old Well Partners, LLC | 12,600 | $264,000 | 0.14% |
| Orbimed Advisors | 535,714 | $11,239,000 | 0.12% |
| Parkwood LLC | 48,059 | $1,008,000 | 0.12% |
| Darwin Global Management, Ltd. | 12,484 | $262,000 | 0.05% |